đ° Full Story
The U.S. Department of Justice announced on April 24, 2026 it will expand federal execution protocols to include firing squads, electrocution and gas asphyxiation and readopt single-drug lethal injection using pentobarbital.
The move, set out in a DOJ report and directed to the Bureau of Prisons, follows difficulties obtaining drugs used in lethal injections and fulfills President Donald Trumpâs pledge to resume and accelerate federal capital punishment.
The department said it has rescinded the Biden-era moratorium and has authorized seeking death sentences against dozens of defendants, with several authorizations already issued.
The DOJ also plans to streamline internal reviews, consider rules to limit clemency and habeas petition delays, and explore expanding federal death row or facilities to permit multiple execution methods.
The announcement highlights enduring legal disputes: condemned inmates can mount Eighth Amendment âcruel and unusualâ challenges, and pharmaceutical firms continue to refuse supplying execution drugs, citing ethical and regulatory constraints.
đ Based On
đ¤ Social Media Insights
Social Summary
The comments add that expanding execution methods responds to drug shortages and medical refusals, shifting the burden to nonmedical actors and raising operational, ethical and legal challenges. That shift is likely to provoke lawsuits, recruitment problems and intensified political debate.







đŹ Commentary